LFB Biomedicaments Bonds, 3.348% 31mar2026, EUR (FIGI BBG011C6XB35, FR00140039X1)
Domestic bonds, Subordinated Unsecured
Domestic bonds, Subordinated Unsecured
Everything you need for fixed income research and monitoring.
Explore the most comprehensive database
1 000 000
bonds
100 000
stocks
175 910
ETF & Funds
100 000
indices
Track your portfolio in the most efficient way
full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register|
LFB Biomedicaments was incorporated in 1994. The company is a French biopharmaceutical group that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins for the treatment of serious and often rare diseases. Its therapeutic focus ...
LFB Biomedicaments was incorporated in 1994. The company is a French biopharmaceutical group that develops, manufactures, and markets plasma-derived medicinal products and recombinant proteins for the treatment of serious and often rare diseases. Its therapeutic focus includes immunology, haemostasis, and intensive care. The company is a subsidiary of the LFB Group, which is owned by the French State.
|
|
|
|
|
|
|
|
|
Explore the most comprehensive database
1 000 000
bonds
100 000
stocks
175 910
ETF & Funds
100 000
indices
Track your portfolio in the most efficient way
full data on over 1 000 000 bonds, 100 000 stocks, 100 000 indices, 17 000 ETF and 150 000 Mutual Funds; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.
Register